Recent studies have demonstrated abnormal expression of several miRNAs in IBD, many of which are involved in the regulation of molecular pathways associated with immune responses, including the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathway [8,9]. Here, NFKB1 is linked to inflammatory bowel disease.